KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares RepurchasedShort-Term Debt repayments
Ratios

Labcorp Holdings (LH) Receivables - Other (2016 - 2025)

Labcorp Holdings' Receivables - Other history spans 12 years, with the latest figure at $156.9 million for Q4 2025.

  • For Q4 2025, Receivables - Other rose 423.0% year-over-year to $156.9 million; the TTM value through Dec 2025 reached $156.9 million, up 423.0%, while the annual FY2025 figure was $156.9 million, 423.0% up from the prior year.
  • Receivables - Other for Q4 2025 was $156.9 million at Labcorp Holdings, up from $156.1 million in the prior quarter.
  • Across five years, Receivables - Other topped out at $827.4 million in Q2 2022 and bottomed at $30.0 million in Q4 2024.
  • The 5-year median for Receivables - Other is $175.8 million (2023), against an average of $377.1 million.
  • The largest annual shift saw Receivables - Other crashed 86.81% in 2023 before it soared 423.0% in 2025.
  • A 5-year view of Receivables - Other shows it stood at $716.8 million in 2021, then crashed by 70.45% to $211.8 million in 2022, then decreased by 12.46% to $185.4 million in 2023, then plummeted by 83.82% to $30.0 million in 2024, then skyrocketed by 423.0% to $156.9 million in 2025.
  • Per Business Quant, the three most recent readings for LH's Receivables - Other are $156.9 million (Q4 2025), $156.1 million (Q3 2025), and $156.1 million (Q2 2025).